Health Care & Life Sciences » Pharmaceuticals | Shanghai Kaibao Pharmaceutical Co. Ltd.

Shanghai Kaibao Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
318,815.40
349,351.70
281,648.50
282,606.80
272,304.70
226,812.40
Depreciation, Depletion & Amortization
29,560.40
38,096.60
51,065.50
51,285.10
49,044.70
48,103.90
Other Funds
1,900.00
65,761.20
21,129.00
1,718.00
26,904.10
59,786.10
Funds from Operations
351,950.00
392,707.80
334,330.80
344,988.60
333,882.90
329,885.70
Changes in Working Capital
81,715.30
110,329.30
9,486.10
29,007.20
69,763.60
50,054
Net Operating Cash Flow
270,234.70
282,378.50
324,844.80
315,981.40
264,119.30
279,831.80
Capital Expenditures
118,283.20
68,740.10
50,400.70
27,030.50
49,243.70
Sale of Fixed Assets & Businesses
-
-
69.80
44.40
8.70
Purchase/Sale of Investments
-
140,000.00
54,938.90
409,437.60
191,034.80
Net Investing Cash Flow
168,283.20
208,740.10
105,269.80
436,423.60
240,269.80
Cash Dividends Paid - Total
131,520.00
136,780.80
128,075.20
82,954.60
107,149.40
Issuance/Reduction of Debt, Net
-
-
30,000.00
-
16,000.00
Net Financing Cash Flow
129,620.00
71,019.60
136,946.20
106,228.90
118,053.50
Net Change in Cash
27,668.50
2,618.80
82,628.90
226,671.20
94,204.10
Free Cash Flow
151,951.50
213,638.40
274,444.10
288,950.90
214,875.60
Deferred Taxes & Investment Tax Credit
630.70
928.20
353.90
1,051.90
278.10
4,816.70
Change in Capital Stock
-
-
-
24,992.40
-
Other Uses
50,000.00
-
-
-
-

About Shanghai Kaibao Pharmaceutical Co.

View Profile
Address
No. 88, Chengpu Road
Shanghai Shanghai 201401
China
Employees -
Website http://www.xykb.com
Updated 07/08/2019
Shanghai Kaibao Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of modern Chinese medicine. Its medicines are in the form of injection, tablets, hard capsules, granules, mixture, syrup, oral liquid, and Chinese medicine extraction; such as Tanreqing injection, doxofylline capsule, Captopril sustained-release tablets, and Hydrochloride pioglitazone tablets. The company was founded on April 12, 2000 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.